1. Introduction {#s1}
===============

Children born preterm with very-low-birth-weight (VLBW) are at higher risk for neurodevelopmental impairments, such as cerebral palsy, developmental delay, and possibly autism spectrum disorder ([@bb0095]; [@bb0056]). Brain abnormalities identified in the neonate may result in higher risk of neurologic impairment and later functional deficits ([@bb0095]). Rapidly developing early brain regions may be selectively vulnerable to injury that may underlie adverse outcome ([@bb0038]; [@bb0051] [@bb0048]). Previous studies have demonstrated widespread differences in white matter (WM) development and regional cortical volumes in infants born VLBW compared to age-matched full-term infants ([@bb0032] [@bb0034] [@bb0085] [@bb0045] [@bb0084]). These structural differences may be biomarkers for early brain injury and adverse outcome.

Near-term neuroimaging data can inform early prognosis for preterm infants and has potential to guide early intervention at a time of optimal neuroplasticity. Specifically, structural MRI can inform about gross brain injury, which has been shown to correlate with outcome ([@bb0051]; [@bb0048]); however, diffusion tensor imaging (DTI) of early WM regions may be a more sensitive biomarker of later neurodevelopment than structural MRI ([@bb004] [@bb0072] [@bb0071] [@bb0015]). DTI quantifies the diffusion properties of tissues and is used to investigate WM microstructure. As the brain develops, water content decreases, extracellular spaces diminish, and cellular microstructures become more complex and organized; these changes can be quantified with DTI ([@bb0024]; [@bb0045]; [@bb0025]; [@bb0064] [@bb0059]).

Scalars obtained from DTI can assess brain development and maturation and include fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) ([@bb0065]). FA reflects the degree of diffusion anisotropy within a voxel, and is determined by fiber diameter and density, myelination, extracellular diffusion, inter-axonal spacing, and intra-voxel fiber-tract coherence. MD is a calculation of average diffusion along the three main axes, relative to the primary direction of diffusion, or AD. AD is thought to reflect fiber coherence and structure of axonal membranes. RD, the mean of diffusivities perpendicular to the primary axis, is thought to represent the degree of myelination ([@bb0078] [@bb0019]). In neonatal WM, FA has been found to increase with age, while MD, AD, and RD decrease with age, likely due to increased fiber organization, axonal coherence, and preliminary myelination ([@bb0015] [@bb0070]). Analyses of DTI scans obtained during the neonatal period may serve as potential predictors of neurodevelopment in children born preterm ([@bb0033] [@bb0071] [@bb0084]).

Previously, we reported DTI findings on regional brain microstructure at near-term age in 45 VLBW preterm infants with no evidence of gross brain abnormalities, a subpopulation of infants reported in the current study ([@bb0070]). WM microstructure was analyzed in 19 subcortical regions. Results indicated a general pattern of central to peripheral regional WM development and of posterior to anterior WM development within regions of the corona radiata, corpus callosum (CC) and internal capsule (IC). Projection fibers of the PLIC demonstrated the highest degree of WM maturation on DTI ([@bb0087] [@bb0070]). The ALIC was less mature but appeared to be one of the most rapidly developing WM regions at near-term age, consistent with early stages of myelination. White matter within the thalamus and globus pallidus (GP) demonstrated higher FA and lower MD values and had larger, less-variable volumes selected, than the putamen and caudate ([@bb0070]), suggesting that these regions may be more reliably assessed at near-term age. These findings, as well as other recent studies ([@bb0025]), suggest that the developmental status of WM regions is an important consideration in the interpretation of neonatal neuroimaging studies, and informed the selection of regions analyzed in the current study.

Rapidly developing brain regions in the neonate may be selectively vulnerable to injury due to morbidities and clinical factors common during the neonatal period. Consequently, abnormal WM development in these regions may be useful for identifying infants with higher risk for adverse outcomes. Known risk factors for poor neurodevelopment following preterm birth include sepsis ([@bb0082] [@bb0075] [@bb0029] [@bb0052]), bronchopulmonary dysplasia ([@bb0077] [@bb0089]; [@bb0040] [@bb0076]), necrotizing enterocolitis (NEC) ([@bb0031] [@bb0088]), and male sex ([@bb0094] [@bb0089] [@bb0071] [@bb008]; [@bb0055]). The aim of this study was to examine the relationship between neonatal physiological risk factors and early brain microstructure in VLBW preterm infants at near-term age, based on qualitative analysis of structural MRI and on semi-automated, atlas-based DTI analysis.

2. Methods {#s2}
==========

2.1. Subjects {#s2.1}
-------------

Near-term scans were obtained from 102 VLBW neonates, representing 76% of eligible participants treated at Lucile Packard Children\'s Hospital (LPCH) between 1/1/10 and 12/31/11. Parents were approached prior to scheduled MRI and consent was obtained for this IRB-approved study. Infants with GA-at-birth ≤32 weeks, birth weight ≤1500 g, and no evidence of genetic disorders or congenital brain abnormalities were included. Sixty-six of the 102 infants had successful DTI scans, collected at the end of routine near-term MRI scans, prior to discharge.

2.2. Neonatal risk factor definition and data collection {#s2.2}
--------------------------------------------------------

Demographic data and neonatal physiological risk factors were assessed in 102 VLBW preterm infants as recorded in the medical record. Demographics included gestational age (GA), birth weight (BW), sex, Apgar score at 5 minutes postnatal (Apgar-at-5 min), multiple births, maternal age, pregnancy-induced hypertension (PIH), and premature rupture of membranes. Physiological risk factors included the presence of bronchopulmonary dysplasia (BPD) defined as having a history of respiratory distress syndrome and treated with oxygen at 36 weeks PMA, sepsis confirmed with positive blood culture ([@bb0079]), necrotizing enterocolitis (NEC), and retinopathy of prematurity (ROP) at any time during hospital stay. Serum levels of mean and peak C-reactive protein (CRP), as well as mean glucose, albumin, and total bilirubin levels during the first 2-weeks of life were recorded. Laboratory values were obtained through a medical record search conducted with Stanford Center for Clinical Informatics and STRIDE (Stanford Translational Research Integrated Database Environment) ([@bb0049]).

Neonatal demographic and physiological risk factors were selected for analysis based on their association with poor neurodevelopmental outcome in previous studies, as detailed in the [Introduction](#s1){ref-type="sec"}. As noted in [Table 1](#t0005){ref-type="table"}, serum levels of CRP, glucose, albumin, and total (T) bilirubin were sampled multiple times over the first two postnatal weeks. Other risk factors were identified based on physician report in the medical record.

2.3. MRI data acquisition {#s2.3}
-------------------------

Brain MRI scans were performed on 3T MRI (GE-Discovery MR750, GE 8-Channel HD head coil) at Lucile Packard Children\'s Hospital at Stanford University. The MRI included T1-weighted, T2-weighted, and diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) scans. A gradient echo 3-plane localizer was used, and an asset calibration was proscribed to utilize parallel imaging. From the 3-plane localizer, T1 images were generated with the following parameters: TE = 9l.0, TR = 2200, FOV = 20 cm, matrix size = 320 × 224, slice thickness 3.0 × 0.5 mm spacing, NEX = 1. T2, DWI, and DTI axial scans were proscribed using a single acquisition, full phase field of view (FOV). The Fast Recovery, Fast Spin Echo T2 scan imaging parameters were as follows: TE = 85 ms, TR = 2500, FOV = 20 cm, matrix size = 384 × 224; slice thickness = 4.0 mm × 0.0 mm spacing. Axial T2 FLAIR parameters were as follows: TE = 140, TR = 9500, FOV = 20 cm, slice thickness = 4.0 mm × 0.0 mm, inversion time = 2300, fluid attenuated inversion recovery matrix = 384 × 224. Axial DWI parameters were as follows: TE = 88.8, TR = 10,000, FOV = 20 cm, slice thickness = 4.0 mm × 0.0 mm spacing, matrix = 128 × 128. The DTI scan was based on a diffusion-weighted, single-shot, spin-echo, echo-planar imaging sequence with a slice thickness of 3.0 mm, a matrix size of 128 × 128, a 90° flip angle, FOV = 20 cm, TE = 88.8 ms, TR = 8000, (b = 1000 s/mm^2^). Diffusion was measured along 25 directions, with three B0 images. Two repetitions were obtained from 64/66 subjects. MRI scans were performed as the routine near-term neuroimaging for preterm infants and the diffusion-weighted sequences were collected at the end of these ˜25-minute MRI scans. Infants were swaddled and fed and typically remained asleep for the duration of the scan. Sedation was not utilized as part of the research protocol and typically was not utilized for routine near-term MRI, although it may have been prescribed according to clinical needs in some cases.

2.4. Radiological assessment {#s2.4}
----------------------------

Brain abnormalities were assessed on structural MRI for degree of abnormality on a scale that defines categories of 1--5, as described in [Table 2](#t0010){ref-type="table"}, and for the number of signal abnormalities observed on T1 and T2 scans in cerebral, intraventricular, internal capsule, basal ganglia, thalamus, and cerebellar regions. Radiological evaluation was performed by an experienced pediatric neuroradiologist, X.S., who was masked to all other participant data. Brain abnormalities identified in the research assessment were consistent with findings of brain abnormalities reported by the clinical neuroradiologist in the patient\'s medical record.

2.5. DTI processing {#s2.5}
-------------------

In a subpopulation of 66 infants, semi-automated, atlas-based DTI was analyzed. Diffusion-weighted images were pre-processed using DTI-Studio based on parameters outlined in [@bb0036] and [@bb0063]. For infants with two repetitions (*n* = 64/66), the best repetition was selected to eliminate images with artifacts or evidence of motion. If no full repetition was usable, a composite repetition was generated based on best image slices (provided the two repetitions were well-registered). Automated Image Registration was performed using an affine transformation to further correct for eddy current distortions and minor head motion.

Each brain image was skull-stripped with ROI Editor using B0 and trace images to distinguish brain matter from intracranial CSF and skull, and manually rotated to align with the JHU neonatal template image. DTI images were processed with DiffeoMap ([[http://www.mristudio.org]{.ul}](http://www.mristudio.org){#inter-ref001}) using FA and trace (the sum of the 3 orthogonal diffusivities per voxel) maps to perform a large deformation diffeomorphic metric mapping (LDDMM) transformation ([@bb0063]). Each brain was normalized to map onto the neonatal atlas and segmented into 126 regions. Based on the trace map, regions \>0.006 mm^2^/s were considered CSF and were excluded from the segmented regions. A threshold of FA \>0.15 was then applied to segment developing WM tracts ([@bb0087]). Regions selected within the FA \>0.15 threshold were then mapped onto the FA and trace maps, and regional values were obtained. MD values were defined as an average of the three directions of diffusion calculated from the trace image.

We examined subcortical WM defined by the JHU parcellation atlas that was well-visualized with near-term MRI and DTI, and known to mediate motor or cognitive function, as illustrated in [Fig. 1](#f0005){ref-type="fig"}. Specifically, we measured FA and MD in commissural fibers of the genu and splenium of the ccs, projection fibers of anterior and posterior limbs of the internal capsule (ALIC and PLIC respectively) and in the WM of subcortical nuclei of the thalamus and globus pallidus (GloP).

These regions were selected for analysis based on prior work that demonstrated that these regions were reliably detected by semi-automated, atlas based analysis of DTI at near-term age ([@bb0070]) based on percent volume above the FA \>0.15 threshold, relative to original volumes identified by the neonatal atlas, as applied to the 45 infants with no evidence of abnormalities on MRI and scanned prior to 40 weeks PMA ([@bb0087]).

2.6. Statistical analysis {#s2.6}
-------------------------

Neonatal demographic and physiological risk factors of GA, CRP, glucose, albumin, and bilirubin were compared in infants with and without brain abnormalities observed on MRI using nonparametric Mann--Whitney U, with a significance level of *p*\< .01 as a correction for multiple comparisons ([Table 1](#t0005){ref-type="table"}). The Spearman's correlation was used to assess associations between neonatal risk factors and brain MRI score and the number of signal abnormalities observed on MRI with a significance level of *p*\< .008, to correct for multiple comparisons ([Table 3](#t0015){ref-type="table"}). Partial correlations were reported between MRI score and number of signal abnormalities observed on MRI and MD values, after controlling for PMA-at-scan with a significance level of *p*\< .01 as a correction for multiple comparisons. Partial correlations were reported between neonatal risk factors and MD values in the CC, ALIC, PLIC, thalamus, and GloP, after controlling for PMA-at-scan with significance level of *p* \< .01---corrected for multiple comparisons ([Table 4](#t0020){ref-type="table"}). Differences between male and female MD values, corrected for PMA-at-scan, were compared using the nonparametric Mann--Whitney test, with a significance level of *p* \< .05. Spearman\'s correlation was used to assess associations among risk factors with continuous values with a significance level of *p*\< .01 ([Table 5](#t0025){ref-type="table"}). The variance inflation factors (VIF) were estimated as a diagnostic for co-linearity between risk factors. Statistical analysis was performed using SPSS Statistics software Version 21 (IBM).

3. Results {#s3}
==========

Demographic characteristics and physiological risk factors of all participants who had MRI (*n* = 102) and the subset population that also had DTI (*n*= 66) are reported in [Table 1](#t0005){ref-type="table"}. Demographic data of the total population was similar to that of the sub-population who had both MRI and DTI. Demographic and physiological risk-factor data for participants with and without brain abnormalities observed on MRI are reported in [Table 1](#t0005){ref-type="table"}. Brain abnormalities were identified on MRI in 38 out of 102 participants (37%), including 21/60 (35%) females and 17/42 (41%) males. Gestational age and BW were similar in those with and without brain abnormalities on MRI. Infants with brain abnormalities observed on MRI had higher incidence of BPD (42% vs. 25%) and sepsis (21% vs. 6%) and higher mean and peak serum CRP levels (0.64 vs. 0.34 mg/dL, *p*= .008; 1.57 vs. 0.67 mg/dL, *p* = .006) compared to those without brain abnormalities observed on MRI.

The correlations between neonatal risk factors are shown in [Table 5](#t0025){ref-type="table"}. Of note, a strong association was found between mean bilirubin and BW (rho = .789, *p* = .000) and between mean albumin and mean bilirubin levels (rho = .604, *p* = .000). For risk factors with continuous values we estimated the variance inflation factors (VIF) as a diagnostic for collinearity and found that mean and peak values of CRP were collinear (VIF ≤ 9.9). Otherwise, among the mean values of risk factors we found no other collinearities, indicating that these mean values provide reasonably independent information for predictive models. The VIF ranged from 1.0 to 3.2, and fell below 10, the conservative criterion for indicating presence of collinearity.

[Table 3](#t0015){ref-type="table"} lists the mean and range of MRI score and the number of signal abnormalities observed on MRI, as well as correlations with physiological risk factors. The higher number of signal abnormalities was correlated to lower scores for Apgar-at-5-minutes and higher mean and peak CRP (*r* = .316, *p*= .002; *r*= .318, *p*= .002).

DTI analysis was performed on the selected brain regions shown in [Fig. 1](#f0005){ref-type="fig"} as defined by the JHU neonatal atlas. Detection of brain abnormalities observed qualitatively on structural MRI compared to DTI findings indicated that the number of signal abnormalities observed on MRI was associated with thalamus MD (left: *r*= .382, *p* = .002; right: *r*= .400, *p* = .001), with trends for genu, splenium, ALIC, and PLIC MD. No associations were found between signal abnormalities observed on MRI and GloP MD.

No associations were found between neonatal risk factors and regional FA values, after controlling for PMA-at-scan.

Genu MD values, corrected for PMA-at-scan, were higher in males compared to females (*p* = .006). No other region demonstrated significant differences between males and females.

[Table 4](#t0020){ref-type="table"} lists associations between neonatal risk factors and MD values of the genu, splenium, PLIC, ALIC, thalamus, and GloP, controlled for PMA-at-scan. No significant association was found between regional MD values and serum CRP levels, only a trend of association between genu MD and peak CRP values was found (*r*= .234, *p* = .068). Thalamus MD demonstrated the strongest associations with neonatal risk factors, higher thalamus MD was associated with lower GA (left: *r*= −.322, *p* = .009; right: *r*= −.381, *p*= .002), lower mean serum albumin (left: *r*= −.276, *p* = .029; right: *r*= −.385, *p*= .002), and lower mean total bilirubin (left: *r*= −.293, *p* = .020; right: *r*= −.337 *p*= .007).

4. Discussion {#s4}
=============

This study examined the relationship between neonatal physiological risk factors and early brain structure that was observed on MRI and quantified using DTI. We found that more than one-third of infants had brain abnormalities observed on structural MRI. Infants with brain abnormalities on MRI demonstrated a similar degree of prematurity, however they had a higher incidence of BPD and sepsis and higher levels of serum CRP over the first 2 weeks of life, compared to those with no brain abnormalities on MRI. Evidence from DTI indicated that the thalamus WM microstructure was most strongly associated with signal abnormalities on structural MRI and with neonatal risk factors.

Advances in neonatal medicine have increased survival rates and improved outcome among VLBW preterm infants. The increased survival of VLBW preterm infants is associated with increased rate of neurodevelopmental impairment, which is currently 3--4 times that of the general population ([@bb0092] [@bb0080]). The incidence of CP in VLBW preterm infants is estimated to be 10--15% ([@bb0047] [@bb0092]; [@bb0071] [@bb0095]), and is defined as "a group of disorders affecting the development of movement and posture, attributed to non-progressive disturbances to the developing fetal or infant brain" ([@bb007] [@bb0073] [@bb0018]). Developmental coordination disorder may affect another 40% of VLBW preterm children of school age ([@bb0095]). Cognitive impairment and/or language delays have been reported in 20--40% of school-age children born VLBW ([@bb003]; [@bb0047] [@bb0027]; [@bb0044]; [@bb0066] [@bb0096] [@bb001] [@bb0069]) and it is estimated that half of these children will require special educational assistance, ([@bb0093]; [@bb0044] [@bb0037] [@bb0023] [@bb0035]). It is not currently possible to predict at near-term age which children will experience these physical and cognitive impairments, limiting our ability to apply early interventions during critical periods of development.

Brain MRI scans are commonly performed at near-term age in very preterm infants, and was envisioned as a potential opportunity to provide early prognosis in preterm infants. However, prognosis based on structural brain MRI has been of limited success in predicting risk for neurodevelopmental problems such as motor deficits, cognitive delay, and language impairment later in life ([@bb0041]; [@bb0010]). DTI of early WM regions may be a more sensitive biomarker of later neurodevelopment than structural MRI ([@bb004]; [@bb0072] [@bb0071] [@bb0015]). Semi-automated, atlas-based DTI analysis has potential for clinical implementation and therefore was used in the current study. Diffusion was analyzed in WM regions which were previously suggested to be reliably detected by semi-automated, atlas based analysis of DTI at near-term age ([@bb0070]) and also mediate motor and cognitive function, domains known to be affected by preterm birth.

4.1. Neonatal risk factors and brain abnormalities observed on structural MRI {#s4.1}
-----------------------------------------------------------------------------

Brain abnormalities were identified in 38/102 infants, including 21/60 females (35%) and 17/42 males (40%). No differences in GA or BW were found, and while infants with brain abnormalities observed on MRI had lower Apgar scores at 5 min after birth, the trend did not reach significance. The value of Apgar scores for prediction of outcome has been debated, but [@bb0046] found a strong correlation between low Apgar scores 5 min after birth and diagnosis of CP before age 5 in children with both low and normal BW. The incidence of BPD was slightly higher in those with brain abnormalities observed on MRI (41%) compared to those without (37%) but did not correlate with MRI score or the number of signal abnormalities on MRI. Bronchopulmonary dysplasia continues to be one of the main risk factors for motor impairments following preterm birth ([@bb0077] [@bb0089]; [@bb0040] [@bb0076]).

Infants with brain abnormalities on MRI had significantly higher mean and peak serum CRP levels compared to those with no brain abnormalities on MRI. Furthermore, number of signal abnormalities observed on MRI correlated to serum CRP levels. CRP is a plasma protein involved in inflammatory response via rapid response to cell death or injury; simultaneously production of other plasma proteins including albumin, decreases, thus, CRP levels have been proposed as a biomarker for sepsis and general inflammatory response in neonates ([@bb0017] [@bb0050]; [@bb0026]). One challenge is determining an optimal cutoff value for CRP levels for sensitive and specific identification of neonatal sepsis ([@bb002] [@bb0013]). Using a combination of biomarkers may hold more diagnostic accuracy than any one biomarker ([@bb0090]). Sepsis is a known risk factor for poor neurodevelopmental prognosis and cerebral palsy among VLBW preterm infants ([@bb0082] [@bb0075] [@bb0029]; [@bb0052] [@bb0088]). Thus, the observed brain abnormalities may be related to inflammatory processes that occurred in the neonatal period.

Abnormal serum concentration of glucose, hormones, and proteins are commonly observed in VLBW preterm infants. Specifically, hypoglycemia was shown to be correlated with increased morbidity and mortality ([@bb0039] [@bb0028]), as well as poor growth ([@bb0068]) in VLBW infants. We did not find significant differences between serum levels of glucose, albumin, or bilirubin in those with or without brain abnormalities observed on MRI. Bilirubin levels observed in our population of neonates were not grossly abnormal, and thus our assessment of the role of these risk factors in brain development is limited.

4.2. Neonatal risk factors and WM microstructure on DTI {#s4.2}
-------------------------------------------------------

### 4.2.1. Corpus callosum {#s4.2.1}

Diffusion imaging scalars were analyzed within association fibers of genu and splenium of the ccs, regions that are in preliminary stages of myelination at near-term age ([@bb0014] [@bb0042] [@bb0067]). The posterior aspects (splenium) of the ccs were previously found to develop earlier than the anterior (genu) aspects ([@bb0087] [@bb0070]). Previous studies also reported that WM structure in the near--term CC may have prognostic value for future motor function ([@bb0021]; [@bb0083]). Males were found to have significantly higher genu MD, corrected for PMA-at-scan. The limited data on sexual dimorphism of neonatal CC development suggests that males may have slightly smaller or less developed CC at near-term age compared to females ([@bb0071]; [@bb0083]). Male gender also was found to be associated with increased risk of adverse outcomes including CP and cognitive deficits following preterm birth ([@bb0094]; [@bb0089] [@bb0071]; [@bb008]; [@bb0055]). Further investigation is needed to explain the physiological and neurological risk factors that increase morbidity among VLBW males.

### 4.2.2. Internal capsule {#s4.2.2}

Diffusion was also analyzed in the projection fibers of the anterior and posterior limbs of the internal capsule. The PLIC includes motor fibers of the cortical spinal tract (CST) and has been found to be relatively more developed than the ALIC at near-term age ([@bb0087]; [@bb0070]). Based on the work of [@bb0097] and [@bb0014], regions of the CST are believed to be undergoing myelination during the near-term period. The CST descends through the posterior third of the PLIC and, consistent with this neuroanatomy, analyses of PLIC DTI at near-term age suggest that it may hold prognostic value for future motor development ([@bb004] [@bb0072] [@bb0071] [@bb0015]). No further associations between neonatal risk factors and PLIC MD were found. This may be explained by the developmental trajectory of the PLIC, which is thought to be particularly vulnerable at the end of the second trimester, when developing vasculature and early myelination processes may increase vulnerability to WM injury ([@bb0032] [@bb0038] [@bb0057] [@bb0051]; [@bb0048]).

### 4.2.3. Thalamus and globus pallidus {#s4.2.3}

We found that thalamus WM microstructure demonstrated the strongest associations with neonatal risk factors, including GA, albumin, and bilirubin. Among VLBW neonates, GA has been found to be inversely correlated with cognitive and motor function later in childhood in several large studies ([@bb0011]; [@bb0020] [@bb0060] [@bb001] [@bb0096]; [@bb0053]). Vulnerability of thalamus WM structure to neonatal risk factors could in part explain the impaired motor and cognitive function associated with preterm birth.

Two recent studies by Ball et al. observed decreased thalamus volume ([@bb006]) and impaired thalamocortical connectivity ([@bb005]) in infants born preterm, compared to age-matched term infants, suggesting that WM impairment may occur due to preterm birth. The thalamus is undergoing significant development and establishing cortical connections during the late second and third trimester of gestation ([@bb0043]), and this process may be disrupted by preterm birth. The thalamus and basal ganglia (consisting of the caudate nucleus, putamen, and globus pallidus) are known to mediate motor processes and have been found to be vulnerable to hypoxic ischemic injury in infants ([@bb0022] [@bb0051] [@bb005]; [@bb0058]). Other investigators have also reported reduced volumes of these subcortical regions in preterm infants, compared to age-matched, term-born controls ([@bb0012]; [@bb0081]).

We found that higher thalamus MD was associated with lower mean albumin and with lower mean total bilirubin. Peak serum bilirubin during the first 2 weeks of life is known to be associated with increased risk of neurodevelopmental impairments ([@bb0061]; [@bb0062]). However, aggressive treatment with phototherapy may cause oxidative injury to cell membranes and increased mortality ([@bb0054]). Thus, the effect of high levels of bilirubin and aggressive bilirubin phototherapy on overall outcome among VLBW infants needs further investigation ([@bb0086]), and is difficult to study independently ([@bb0030]).

Recent studies suggest that unbound bilirubin is more informative than total serum bilirubin in prediction of neurodevelopmental trajectories in VLBW infants ([@bb0016]; [@bb0062]). The ratio of bound/unbound bilirubin is moderated by the availability of albumin, as bilirubin binds to albumin, preventing it from crossing the blood--brain barrier ([@bb0091]; [@bb009]). Thus, low albumin levels in the preterm infant may also be involved in the cytotoxicity of bilirubin and may hold prognostic value. Because unbound bilirubin is difficult to measure compared to total bilirubin, the ratio of total bilirubin/albumin may allow for estimation of exposure of the neonatal brain to unbound bilirubin ([@bb0074]).

The strong association found between albumin and total bilirubin levels in the current study suggests that low albumin levels may be primarily responsible for both increased thalamus MD and lower bilirubin levels. Phototherapy to reduce bilirubin levels is administered based on BW, and thus infants with lower BW will have lower bilirubin levels ([Table 5](#t0025){ref-type="table"}). This may also contribute to the relationship between low bilirubin and high thalamus MD ([Table 4](#t0020){ref-type="table"}). However, further study is required to examine the interactions between bilirubin, albumin, and sepsis and how they individually contribute to increased risk for neurodevelopment impairments. Furthermore, albumin levels are decreased as a result of inflammation, and ischemia-modified albumin levels may be used as prognostic tools for sepsis in neonates ([@bb0099] [@bb0098]).

5. Conclusion {#s5}
=============

This study examined the relationship between neonatal physiological risk factors and early brain structure in VLBW preterm infants. DTI was assessed to examine evidence of selective vulnerability of brain regions, which may ultimately serve to predict outcome and guide neuroprotective treatment for preterm infants. We used semi-automated atlas-based analysis of DTI because of its potential for clinical neuroimaging for neonates. We observed that the thalamus demonstrated the most associations with neonatal risk factors, and although these were low to moderate correlations, the findings may reflect selective vulnerability of the thalamus at near-term age. Limitations of this study include the cross-sectional design, the difficulty in studying risk factors independently, and the low incidence of some risk factors affecting brain development (e.g. NEC). Sequential neuroimaging during the near-term period would be helpful in revealing trajectories of development and how they relate to neonatal risk factors. Furthermore, correlation between clinical risk factors and regional brain structure and microstructure at near term age does not describe the relationship between brain abnormality and neurodevelopmental impairment. Results may have been influenced by accuracy of automated ROI generation, which is better for larger ROIs. As in any DTI investigation, results may also be influenced by differences in SNR between brain regions. Future studies using different diffusion-weighted analyses and scan sequences should be performed to further investigate WM structure in VLBW neonates and their relationship with neonatal physiological risk factors. Future studies may determine whether associations between neonatal risk factors and regional patterns of microstructural development could provide early prognostic biomarkers for future function that may ultimately guide early intervention aimed at reducing neurodevelopmental disabilities.

We wish to thank Dr. John Tamaresis for valuable statistical consultation. This research is supported in part by the NIH Clinical and Translational Science Award UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) and for the Stanford Center for Clinical Informatics. STRIDE (Stanford Translational Research Integrated Database Environment) is a research and development project at Stanford University to create a standards-based informatics platform supporting clinical and translational research, and by the Lucile Packard Foundation for Children\'s Health. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under grant No. DGE-1147470.
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###### 

Demographic and physiological risk factors.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                         All Neonates\   Normal MRI\      Abnormal MRI\                                    Neonates with DTI\
                                                                         n = 102         n = 64           n = 38                                           n = 66
  ---------------------------------------------------------------------- --------------- ---------------- ------------------------------------------------ --------------------
  Males n (% with abnormal MRI)                                          42              25               17 (40%)                                         25

  Females n (%with abnormal MRI)                                         60              39               21 (35%)                                         41

  Gestational age (weeks) mean (SD)                                      28.7 (2.4)      28.9 (2.3)       28.3 (2.6)                                       28.9 (2.3)

  Birth-weight (g) mean (SD)                                             108 (279)       1102 (276)       1162 (285)                                       109 (266)

  PMA-at-scan (weeks) mean (SD)                                          36.6 (1.8)      36.5 (1.6)       36.8 (2.0)                                       36.5 (1.3)

  Maternal age (years) mean (SD)                                         31.6 (6.0)      32.2 (5.4)       30.6 (6.8)                                       31.9 (6.1)

  Multiple births mean (SD)                                              1.75 (.95)      1.8 (.88)        1.7 (1.1)                                        1.8 (.92)

  Apgar at-5-min mean (SD)                                               7.4 (1.8)       7.7 (1.6)        6.8 (2.2)                                        7.4 (1.7)

  Days on ventilation mean (SD)                                          11.1 (18.4)     7.7 (13.9)       16.7 (23.2)                                      8.7 (14.4)

  Bronchopulmonary dysplasia, n (%)                                      32 (31%)        16 (25%)         16 (42%)                                         18 (27%)

  Necrotizing enterocolitis, n (%)                                       14 (14%)        8 (13%)          6 (16%)                                          7 (11%)

  Retinopathy of prematurity, n (%)                                      72 (71%)        40 (63%)         32 (84%)                                         45 (68%)

  Sepsis [a](#ngtbl1.1){ref-type="table-fn"}, n (%)                      12 (12%)        4 (6%)           8 (21%)                                          59 (9%)

  Mean CRP[b](#ngtbl1.2){ref-type="table-fn"}, mg/dL mean (SD)           .45 (.58)       .34 (.45)        .64 (.72)[f](#ngtbl1.6){ref-type="table-fn"}     .38 (.49)

                                                                                         ***p* = .008**                                                    

  Peak CRP[b](#ngtbl1.2){ref-type="table-fn"}, mg/dL mean (SD)           1.00 (1.49)     .67 (.98)        1.57 (1.99)[f](#ngtbl1.6){ref-type="table-fn"}   .83 (1.30)

                                                                                         ***p* = .006**                                                    

  Mean glucose[c](#ngtbl1.3){ref-type="table-fn"}, mg/dL mean (SD)       103.1 (20.9)    101.8 (19.3)     105.2 (23.7)                                     103.0 (18.3)

                                                                                         *p* = .488                                                        

  Mean albumin[d](#ngtbl1.4){ref-type="table-fn"}, mg/dL, mean (SD)      2.4 (.3)        2.4 (0.3)        2.4 (0.4)                                        2.4 (.3)

                                                                                         *p* = .185                                                        

  Mean T bilirubin[e](#ngtbl1.5){ref-type="table-fn"} mg/dL, mean (SD)   5.4 (1.3)       5.4 (1.3)        5.4 (1.4)                                        5.3 (1.3)

                                                                                         *p* = .802                                                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Confirmed with a positive blood culture.

CRP sampled an average of 3.72 (1.9) times in the first 2-weeks.

Glucose sampled an average of 13.6 (5.8) times in the first 2-weeks.

Albumin sampled 9.7 (6.1) times in the first 2-weeks.

Total bilirubin sampled 13.6 (2.9) times in the first 2-weeks.

Significantdifference between infants with normal versus abnormal MRI assessed with Mann--Whitney U using two-tailed significance of ***p* \< .01** for serum CRP, glucose, albumin, and bilirubin.

###### 

Categories used to classify structural MRI findings.

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Category   Radiological findings on MRI
  ---------- ------------------------------------------------------------------------------------------------------------------------------------
  C1         No abnormality.

  C2         Minimal abnormality, such as subependymal hemorrhage or mineralization\
             (e.g. sequelae of germinal matrix hemorrhage) with or without mild ventriculomegaly, with or without mild IVH.

  C3         Moderate to severe ventriculomegaly, with or without IVH

  C4         Parenchymal abnormality, including evidence of gray and/or white matter injury due to hemorrhage or ischemia, with or without IVH.

  C5         Congenital malformation (excluded from further analyses)\
  -----------------------------------------------------------------------------------------------------------------------------------------------

###### 

Correlations between neonatal risk factors and brain MRI score and number of signal abnormalities on MRI at near-term age.

  -----------------------------------------------------------------------------------------------------------------------------------
  Neonatal risk factors      MRI score\              \# of signal abnormalities\   
                             Range = 1--4\           Range = 0--13\                
                             Mean (SD) = 2.2 (1.0)   Mean (SD) = 2.1 (3.0)         
  -------------------------- ----------------------- ----------------------------- --------------------------------------------------
  Gestational age at birth   Rho                     −.140                         −.197

                             Sig.                    *p* = .163                    *p* = .048

  Apgar at 5 min             Rho                     −.236                         −.303

                             Sig.                    *p* = .031                    *p***= .005**[a](#ngtbl3.1){ref-type="table-fn"}

  C-reactive protein         Rho                     .220                          .316

                             Sig.                    *p* = .031                    *p***= .002**[a](#ngtbl3.1){ref-type="table-fn"}

  Peak C-reactive protein    Rho                     .211                          .318

                             Sig.                    *p* = .039                    *p***= .002**[a](#ngtbl3.1){ref-type="table-fn"}

  Glucose                    Rho                     −.001                         −.028

                             Sig.                    *p* = .994                    *p* = .787

  Albumin                    Rho                     − .170                        −.193

                             Sig.                    *p* = .095                    *p* = .058

  Total bilirubin            Rho                     −.077                         −.065

                             Sig.                    *p* = .452                    *p* = .528
  -----------------------------------------------------------------------------------------------------------------------------------

Spearman's rho, two-tailed significance *p* \< .008.

###### 

Correlations between neonatal risk factors and near-term regional brain white matter microstructure mean diffusivity (MD), corrected for PMA-at-scan, are reported for the genu, splenium (Splen), posterior limb of internal capsule (PLIC), anterior limb of internal capsule (ALIC), thalamus (Thal), and globus pallidus, (GloP). Risk factors include gestational age at birth (GA), mean and peak serum C-reactive protein (CRP), and mean serum glucose, albumin, and total (T) bilirubin.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                  Genu\   Splen\   L ALIC,\   R ALIC,\   L PLIC,\   R PLIC,\   L Thal,\                                   R Thal,\                                   L GloP,\   R GloP, MD
                                  MD      MD       MD         MD         MD         MD         MD                                         MD                                         MD         
  ------------------------ ------ ------- -------- ---------- ---------- ---------- ---------- ------------------------------------------ ------------------------------------------ ---------- ------------
  GA (*N* = 66)            r      .116    −.176    .160       .065       .067       .033       −.322[a](#ngtbl4.1){ref-type="table-fn"}   −.381[a](#ngtbl4.1){ref-type="table-fn"}   −.088      −.144

                           Sig.   .359    .160     .203       .608       .596       .794       **.009**                                   **.002**                                   .485       .252

  CRP (*N* = 63)           r      .189    −.152    −.025      −.229      .008       −.128      −.125                                      −.125                                      .000       −.040

                           Sig.   .141    .239     .847       .073       .954       .321       .334                                       .331                                       .999       0.757

  Peak CRP (*N* = 63)      r      .234    −168     .028       −.158      .010       −.120      −.075                                      −.057                                      −.039      −.024

                           Sig.   .068    .191     .832       .221       .941       .355       .564                                       .661                                       .763       .852

  Glucose (*N* = 64)       r      −.170   .028     −.178      −.104      −.175      −.189      .043                                       .130                                       −.092      −.038

                           Sig.   .183    .825     .163       .415       .170       .138       .740                                       .310                                       .474       .769

  Albumin (*n* = 64)       r      .036    −.004    −.059      −.136      −.149      −.106      −.276                                      −.385[a](#ngtbl4.1){ref-type="table-fn"}   −.141      −.076

                           Sig.   .780    .975     .645       .286       .244       .408       .029                                       **.002**                                   .272       .551

  T Bilirubin (*n* = 64)   r      .111    −.095    −.006      −.105      −.023      −.074      −.293                                      −.337[a](#ngtbl4.1){ref-type="table-fn"}   −.145      −.196

                           Sig.   .387    .461     .963       .411       .861       .566       .020                                       **.007**                                   .257       .123
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Partial correlation (r), two-tailed significance *p* \< .01.

###### 

Correlations among neonatal risk factors. Risk factors include gestational age at birth (GA), mean and peak serum C-reactive protein (CRP), and mean serum glucose, albumin, and total (T) bilirubin.

                    GA     CRP                                        Peak CRP                                   Glucose                                    Albumin                                    Bilirubin                                  
  ----------------- ------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------
  GA                Rho    1                                          −.196                                      −.258                                      −.553[a](#ngtbl5.1){ref-type="table-fn"}   .573[a](#ngtbl5.1){ref-type="table-fn"}    .647[a](#ngtbl5.1){ref-type="table-fn"}
                    Sig.                                              .055                                       .011                                       .000                                       .000                                       .000
                    N      102                                        97                                         97                                         98                                         98                                         98
  CRP               Rho    −.196                                      1                                          .973[a](#ngtbl5.1){ref-type="table-fn"}    .033                                       −.338[a](#ngtbl5.1){ref-type="table-fn"}   −.262[a](#ngtbl5.1){ref-type="table-fn"}
                    Sig.   .055                                                                                  .000                                       0.752                                      .001                                       .010
                    N      97                                         97                                         97                                         97                                         97                                         97
  Peak CRP          Rho    −.258                                      .973[a](#ngtbl5.1){ref-type="table-fn"}    1                                          .083                                       −.398[a](#ngtbl5.1){ref-type="table-fn"}   −.320[a](#ngtbl5.1){ref-type="table-fn"}
                    Sig.   .011                                       .000                                                                                  .420                                       .000                                       .001
                    N      97                                         97                                         97                                         97                                         97                                         97
  Glucose           Rho    −.553[a](#ngtbl5.1){ref-type="table-fn"}   .033                                       .083                                       1                                          −.363[a](#ngtbl5.1){ref-type="table-fn"}   −.433[a](#ngtbl5.1){ref-type="table-fn"}
                    Sig.   .000                                       .752                                       .420                                                                                  .000                                       .000
                    N      98                                         97                                         97                                         98                                         98                                         98
  Albumin           Rho    .573[a](#ngtbl5.1){ref-type="table-fn"}    −.338[a](#ngtbl5.1){ref-type="table-fn"}   −.398[a](#ngtbl5.1){ref-type="table-fn"}   −.363[a](#ngtbl5.1){ref-type="table-fn"}   1                                          .609[a](#ngtbl5.1){ref-type="table-fn"}
                    Sig.   .000                                       .001                                       .000                                       .000                                                                                  .000
                    N      98                                         97                                         97                                         98                                         98                                         98
  Total bilirubin   Rho    .647[a](#ngtbl5.1){ref-type="table-fn"}    −.262                                      −.320[a](#ngtbl5.1){ref-type="table-fn"}   −.433[a](#ngtbl5.1){ref-type="table-fn"}   .609[a](#ngtbl5.1){ref-type="table-fn"}    1
                    Sig.   .000                                       .010                                       .001                                       .000                                       .000                                       
                    N      98                                         97                                         97                                         98                                         98                                         98

Spearman's correlation (rho), two-tailed significance *p* \< .01.
